Neuro-Oncology Reviews

Volume 28 Number 19
10 July 2026

Home > Publications > Neuro-Oncology Reviews > Volume 28, Year 2026 > Number 19, 10 July

He Y, Song W, Li S, Guo J.
The glioblastoma ecosystem: clonal evolution, heterogeneity, and therapeutic resistance.
Front Cell Dev Biol. 2026 Jul 1;14:1834106. doi: 10.3389/fcell.2026.1834106. PMID: 42459835. ˍ

Putra MAR, Ghozali SAS, Annisa MF.
Focused ultrasound-induced blood-brain barrier modulation for drug delivery in recurrent glioblastoma: A systematic review.
Indian J Med Res. 2026 Jul 1;164(1):19-28. doi: 10.25259/IJMR_2529_2025. PMID: 42397830. ˍ

Dieli C, Costanzo R, Corsale AM, Paolini F, Di Simone M, Avellone C, Dieli F, Iacopino DG, Marchiafava S, Maugeri R, Meraviglia S.
CAR-T cell therapy in glioblastoma: from αβ to γδ T-cell platforms.
Oncol Rev. 2026 Jul 2;20:1808229. doi: 10.3389/or.2026.1808229. PMID: 42466093. ˍ

Yang J, Li J, Jin M, Lu Y, Zhang L.
The immunosuppressive tumor microenvironment in glioblastoma.
Front Immunol. 2026 Jul 2;17:1806996. doi: 10.3389/fimmu.2026.1806996. PMID: 42465775. ˍ

Achari E, Ahmady-Nield F, Sharma A, Schmidt-Wolf IGH, Maciaczyk J, Luwor RB, Achuthan AA.
Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment.
Immunol Cell Biol. 2026 Jul 3. doi: 10.1111/imcb.70144. PMID: 42396877. ˍ

Rashidi F, Sabahi M, Allahdadi A, Delbari P, Habibi MA, Tavani SF, Zare A, Sattari SA, Alomari S, Mofatteh M, Mashayekhi MS, Shahjouei S, Ranjan S, Adada B, Chamoun RB, Borghei-Razavi H.
The efficacy and safety of poly ADP-ribose polymerase (PARP) inhibitors in patients with high-grade glioma (HGG): A systematic review and meta-analysis.
J Neuroimmunol. 2026 Jul 4;419:579021. doi: 10.1016/j.jneuroim.2026.579021. PMID: 42424804. ˍ

Kenaan N, Bashour G, Kheyrbek N, Haddad S, Sardini M, Sabbagh M, Hannouneh ZA, Ansstas G, Alshehabi Z.
Advances and Future Expectations in Oncolytic Virus Therapy for Glioblastoma: A Systematic Review of Clinical Trials.
Clin Med Insights Oncol. 2026 Jul 5;20:11795549261466431. doi: 10.1177/11795549261466431. PMID: 42416515. ˍ

Ramireddy VVS, Shaikh RG, Pednekar AR, Tripathi D, Munde CT, Wagh K.
A Systematic Literature Review of Emerging Advances in Neurological Disorders: Diagnostic Innovations, Therapeutic Strategies, and Future Directions.
Cureus. 2026 Jul 7;18(7):e112202. doi: 10.7759/cureus.112202. PMID: 42565151. ˍ

McAbee JH, Laird DG, Gajjar A, Hersh DS, Shimony N, Aquilina K, Klimo P Jr.
Surgical resection in medulloblastoma: a crossroads in the molecular era.
Childs Nerv Syst. 2026 Jul 8;42(1):290. doi: 10.1007/s00381-026-07355-0. PMID: 42418015. ˍ

Duerinck J, Van Den Bent M, Brandal P, Minniti G, Galldiks N, Franceschi E, Geurts M, Berghoff AS, Renovanz M, Brandsma D, Snijders TJ, Weller M, Short SC, Platten M, Le Rhun E, Preusser M, Schweizer L, Albert NL, Furtner J, Razis E.
The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis.
Neuro Oncol. 2026 Jul 9:noag153. doi: 10.1093/neuonc/noag153. PMID: 42423280. ˍ

Mittelbronn M.
Neurooncology: 2026 update.
Free Neuropathol. 2026 Jul 9;7:17. doi: 10.17879/freeneuropathology-2026-9688. PMID: 42445897. ˍ

Montiel Equihua C, Baxter JS, Molenaar JJ, Areso I, Abbou S, Anderson J, Andre N, Ayrault O, Blanc P, Carpenter N, Daems S, D'Angiolella V, Danielson L, Donovan L, Durbin AD, Fouladi M, Gajjar A, Gilbertson R, Giraud G, Gottardo N, Hill R, Kearns P, Kool M, Lass G, Marino S, Mueller S, Newman S, Olson J, Patel S, Pfister SM, Rainsbury J, Ramaswamy V, Rutkowski S, Straathof K, Swartling FJ, Wechsler-Reya RJ, Pearson ADJ, Jenkinson D, Doz F, Clifford SC; LifeArc; Innovative Therapies for Children with Cancer (ITCC); Cancer Research UK; Cancer Grand Challenge Protect team.
Paediatric therapeutic development workshop on medulloblastoma.
Br J Cancer. 2026 Jul 9. doi: 10.1038/s41416-026-03533-8. PMID: 42426296. ˍ

Pailas A, Vales de Almeida AC, Torres-Fernández M, Chalmers A, Mittelbronn M, Van Dyck E.
Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy.
Neurooncol Adv. 2026 Jul 9;8(1):vdag177. doi: 10.1093/noajnl/vdag177. PMID: 42549406. ˍ

Ren L, Liu C, Chen W, Wang Y, Rammes G, Neckel PH, Klingl A, Istvanffy R, Friess H, Ceyhan GO, Yang Q, Demir IE.
Neuron-tumor communication in solid tumors: from bona fide synapses to pseudo-synaptic neural interfaces.
Trends Cancer. 2026 Jul 9:S2405-8033(26)00136-6. doi: 10.1016/j.trecan.2026.06.008. PMID: 42425835. ˍ

Wu J, Wang N.
Current Treatment Options for Adult Grade 2 IDH-mutant Diffuse Gliomas in the Vorasidenib Era: Patient Selection, Sequencing, and Practical Management.
Curr Treat Options Oncol. 2026 Jul 10;27(1):36. doi: 10.1007/s11864-026-01401-4. PMID: 42430039˰ ˍ